Mitochondrial permeability transition pore plays a role in the cardioprotection of CB2 receptor against ischemia-reperfusion injury

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 3, 2014, Pages 205-214

  Li, Qian ^a   Guo, Hui cai ^a   Maslov, Leonid N ^b   Qiao, Xiao wen ^c   Zhou, Jing jing ^a   Zhang, Yi ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

^c Xinji Municipal Hospital of Traditional Chinese Medicine   (China)

Author keywords

Cardioprotection; CB2 receptor; ERK1 2; Ischemia reperfusion; JWH133; Mitochondrial permeability transition pore; Rat

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ATRACTYLOSIDE; CANNABINOID 2 RECEPTOR; CYTOCHROME C; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART PROTECTION; ISOLATED HEART; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY;

ANIMALS; CANNABINOIDS; CYTOCHROMES C; MALE; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2;

EID: 84900362528     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2013-0293     Document Type: Article

References (25)

1. Argaud, L., Gateau-Roesch, O., Muntean, D., Chalabreysse, L., Loufouat, J., Robert, D., et al. 2005. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J. Mol. Cell. Cardiol. 38(2): 367-374. doi:10.1016/j.yjmcc.2004.12.001. PMID:15698843.
2. Baines, C.P. 2009. The mitochondrial permeability transition pore and ischemia- reperfusion injury. Basic Res. Cardiol. 104(2): 181-188. doi:10.1007/s00395-009- 0004-8. PMID:19242640.
3. Deng, T., Zhang, L., Ge, Y., Lu, M., and Zheng, X. 2009. Redistribution of intracellular calcium and its effect on apoptosis in macrophages: Induction by oxidized LDL. Biomed. Pharmacother. 63(4): 267-274. doi:10.1016/j.biopha. 2008.04.008. PMID:18602792.
4. Gunter, K.K., and Gunter, T.E. 1994. Transport of calcium by mitochondria. J. Bioenerg. Biomembr. 26(5): 471-485. doi:10.1007/BF00762732. PMID:7896763.
5. Halestrap, A.P., Clarke, S.J., and Javadov, S.A. 2004. Mitochondrial permeability transition pore opening during myocardial reperfusion: a target for cardioprotection. Cardiovasc. Res. 61(3): 372-385. doi:10.1016/S0008-6363(03)00533-9. PMID:14962470.
6. Hausenloy, D.J., and Yellon, D.M. 2004. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc. Res. 61(3): 448-460. doi:10.1016/j. cardiores.2003.09.024. PMID:14962476.
7. Hausenloy, D.J., Boston-Griffiths, E.A., and Yellon, D.M. 2012. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. Br. J. Pharmacol. 165(5): 1235-1245. doi:10.1111/j.1476-5381.2011.01700.x. PMID:21955136.
8. Hiley, C.R. 2009. Endocannabinoids and the heart. J. Cardiovasc. Pharmacol. 53(4): 267-276. doi:10.1097/FJC.0b013e318192671d. PMID:19276990.
9. ILAR (Institute of Laboratory Animal Resources). 1996. Guide for the Care and Use of Laboratory Animals. NIH Publication No. 85-23 (revised 1996). National Academy Press, Washington, D.C. [Available from http://www.nap.edu/ openbook.php?record_id=5140
10. Jassem, W., Fuggle, S.V., Rela, M., Koo, D.D., and Heaton, N.D. 2002. The role of mitochondria in ischemia/reperfusion injury. Transplantation, 73(4): 493-499. doi:10.1097/00007890-200202270-00001. PMID:11889418.
11. Javadov, S., and Karmazyn, M. 2007. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell. Physiol. Biochem. 20(1-4): 1-22. doi:10.1159/ 000103747. PMID:17595511.
12. Lepicier, P., Bouchard, J.F., Lagneux, C., and Lamontagne, D. 2003. Endocannabinoids protect the rat isolated heart against ischaemia. Br. J. Pharmacol. 139(4): 805-815. doi:10.1038/sj.bjp.0705313. PMID:12813004.
13. Lepicier, P., Bibeau-Poirier, A., Lagneux, C., Servant, M.J., and Lamontagne, D. 2006. Signaling pathways involved in the cardioprotective effects of cannabinoids. J. Pharmacol. Sci. 102(2): 155-166. doi:10.1254/jphs.CRJ06011X. PMID: 17031075.
14. Li, Q., Wang, F., Zhang, Y.M., Zhou, J.J., and Zhang, Y. 2013. Activation of cannabinoid type 2 receptor by JWH133 protects heart against ischemia/ reperfusion-induced apoptosis. Cell. Physiol. Biochem. 31(4-5): 693-702. doi: 10.1159/000350088. PMID:23711495.
15. Ma, H., Huang, X., Li, Q., Guan, Y., Yuan, F., and Zhang, Y. 2011. ATP-dependent potassium channels and mitochondrial permeability transition pores play roles in the cardioprotection of theaflavin in young rat. J. Physiol. Sci. 61(4): 337-342. doi:10.1007/s12576-011-0148-9. PMID:21503789.
16. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., and Bonner, T.I. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346(6284): 561-564. doi:10.1038/346561a0. PMID:2165569.
17. Montecucco, F., Lenglet, S., Braunersreuther, V., Burger, F., Pelli, G., Bertolotto, M., et al. 2009. CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion. J. Mol. Cell. Cardiol. 46(5): 612-620. doi:10.1016/j.yjmcc.2008.12.014. PMID:19162037.
18. Pacher, P., and Hasko, G. 2008. Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 153(2): 252-262. doi:10.1038/sj.bjp.0707582. PMID:18026124.
19. Pertwee, R.G. 1997. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74(2): 129-180. doi:10.1016/S0163-7258(97)82001-3. PMID: 9336020.
20. Rajesh, M., Pan, H., Mukhopadhyay, P., Batkai, S., Osei-Hyiaman, D., Hasko, G., et al. 2007. Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J. Leukoc. Biol. 82(6): 1382-1389. doi:10.1189/jlb. 0307180. PMID:17652447.
21. Steffens, S., and Pacher, P. 2012. Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies. Br. J. Pharmacol. 167(2): 313-323. doi:10.1111/j.1476-5381.2012.02042.x. PMID:22612332.
22. Sun, C.K., Zhang, X.Y., Sheard, P.W., Mabuchi, A., and Wheatley, A.M. 2005. Change in mitochondrial membrane potential is the key mechanism in early warm hepatic ischemia-reperfusion injury. Microvasc. Res. 70(1-2): 102-110. doi:10. 1016/j.mvr.2005.04.003. PMID:15893342.
23. Sun, Y., Zhang, Y., Yan, M., Wu, Y., and Zheng, X. 2009. B-type natriuretic peptide-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition. Biol. Pharm. Bull. 32(9): 1545-1551. doi:10.1248/bpb.32.1545. PMID:19721230.
24. Weiss, J.N., Korge, P., Honda, H.M., and Ping, P. 2003. Role of the mitochondrial permeability transition in myocardial disease. Circ. Res. 93(4): 292-301. doi: 10.1161/01.RES.0000087542.26971.D4. PMID:12933700.
25. Zoratti, M., and Szabo, I. 1995. The mitochondrial permeability transition. Biochim. Biophys. Acta, 1241(2): 139-176. doi:10.1016/0304-4157(95)00003-A. PMID: 7640294.